ITRM
Price
$0.77
Change
+$0.01 (+1.32%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
34.15M
30 days until earnings call
ORMP
Price
$2.38
Change
-$0.10 (-4.03%)
Updated
Oct 8, 04:59 PM (EDT)
Capitalization
98M
37 days until earnings call
Interact to see
Advertisement

ITRM vs ORMP

Header iconITRM vs ORMP Comparison
Open Charts ITRM vs ORMPBanner chart's image
Iterum Therapeutics
Price$0.77
Change+$0.01 (+1.32%)
Volume$11.48K
Capitalization34.15M
Oramed Pharmaceuticals
Price$2.38
Change-$0.10 (-4.03%)
Volume$309
Capitalization98M
ITRM vs ORMP Comparison Chart in %
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ITRM vs. ORMP commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ITRM is a StrongBuy and ORMP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 09, 2025
Stock price -- (ITRM: $0.76 vs. ORMP: $2.39)
Brand notoriety: ITRM and ORMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ITRM: 112% vs. ORMP: 252%
Market capitalization -- ITRM: $34.15M vs. ORMP: $98M
ITRM [@Biotechnology] is valued at $34.15M. ORMP’s [@Biotechnology] market capitalization is $98M. The market cap for tickers in the [@Biotechnology] industry ranges from $107.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ITRM’s FA Score shows that 1 FA rating(s) are green whileORMP’s FA Score has 0 green FA rating(s).

  • ITRM’s FA Score: 1 green, 4 red.
  • ORMP’s FA Score: 0 green, 5 red.
According to our system of comparison, ORMP is a better buy in the long-term than ITRM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ITRM’s TA Score shows that 7 TA indicator(s) are bullish while ORMP’s TA Score has 4 bullish TA indicator(s).

  • ITRM’s TA Score: 7 bullish, 2 bearish.
  • ORMP’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ITRM is a better buy in the short-term than ORMP.

Price Growth

ITRM (@Biotechnology) experienced а +14.32% price change this week, while ORMP (@Biotechnology) price change was -6.27% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.02%. For the same industry, the average monthly price growth was +18.92%, and the average quarterly price growth was +86.47%.

Reported Earning Dates

ITRM is expected to report earnings on Nov 07, 2025.

ORMP is expected to report earnings on Nov 14, 2025.

Industries' Descriptions

@Biotechnology (+9.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ORMP($98M) has a higher market cap than ITRM($34.2M). ORMP YTD gains are higher at: -1.240 vs. ITRM (-56.791). ITRM has higher annual earnings (EBITDA): -20.51M vs. ORMP (-22.07M). ORMP has more cash in the bank: 97.9M vs. ITRM (13M). ORMP has less debt than ITRM: ORMP (912K) vs ITRM (32.6M). ORMP has higher revenues than ITRM: ORMP (2M) vs ITRM (0).
ITRMORMPITRM / ORMP
Capitalization34.2M98M35%
EBITDA-20.51M-22.07M93%
Gain YTD-56.791-1.2404,581%
P/E RatioN/A20.91-
Revenue02M-
Total Cash13M97.9M13%
Total Debt32.6M912K3,575%
FUNDAMENTALS RATINGS
ITRM vs ORMP: Fundamental Ratings
ITRM
ORMP
OUTLOOK RATING
1..100
1772
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
68
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
6547
P/E GROWTH RATING
1..100
245
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORMP's Valuation (68) in the Pharmaceuticals Other industry is in the same range as ITRM (84) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ITRM’s over the last 12 months.

ORMP's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as ITRM (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ITRM’s over the last 12 months.

ORMP's SMR Rating (95) in the Pharmaceuticals Other industry is in the same range as ITRM (100) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ITRM’s over the last 12 months.

ORMP's Price Growth Rating (47) in the Pharmaceuticals Other industry is in the same range as ITRM (65) in the Biotechnology industry. This means that ORMP’s stock grew similarly to ITRM’s over the last 12 months.

ITRM's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for ORMP (45) in the Pharmaceuticals Other industry. This means that ITRM’s stock grew somewhat faster than ORMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ITRMORMP
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 8 days ago
90%
Bearish Trend 6 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ITRM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNCKF0.500.01
+2.48%
Galleon Gold Corp.
ERNXY29.680.58
+1.99%
Euronext NV
STBMF0.35N/A
N/A
St. Barbara Ltd.
VSBC1.00N/A
N/A
VitaSpring Biomedical Co. Ltd.
VIIQ0.20N/A
N/A
VisitIQ Corp.

ITRM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ITRM has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ITRM jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITRM
1D Price
Change %
ITRM100%
+0.63%
PLRX - ITRM
42%
Loosely correlated
+3.38%
ACRS - ITRM
34%
Loosely correlated
+3.26%
ORMP - ITRM
34%
Loosely correlated
-3.63%
TARA - ITRM
32%
Poorly correlated
+5.19%
RNAZ - ITRM
30%
Poorly correlated
+21.11%
More

ORMP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORMP has been loosely correlated with BTAI. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if ORMP jumps, then BTAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORMP
1D Price
Change %
ORMP100%
-3.63%
BTAI - ORMP
44%
Loosely correlated
+6.40%
INO - ORMP
44%
Loosely correlated
+7.11%
MBIO - ORMP
44%
Loosely correlated
-0.57%
ZNTL - ORMP
43%
Loosely correlated
+5.81%
RVMD - ORMP
42%
Loosely correlated
+2.68%
More